| How Fortune 500 Companies Are Secretly Playing the Crypto Market |
Every year, one of the best strategies is the Dogs of the Dow. You simply buy a basket of underperformers on the Dow that pay dividends, and sell by the end of the year.
For 2025, here’s how the Dogs are doing with just days to go.
- Verizon (VZ), which yields 6.85%, started the year at around $38. It’s. now up to $40.
- Chevron (CVX), which yields 4.54%, ran from about $142 to $150.50.
- Johnson & Johnson (JNJ), which yields 2.5%, ran from $142 to $207.78.
- Amgen (AMGN), which yields 3.02%, ran from about $258 to $334.
- Merck (MRK), which yields 3.19%, ran from about $98 to $106.45.
- Coca-Cola (KO), which yields 2.91%, jumped from $61 to $70.11 so far.
- IBM (IBM), which yields 2.21%, ran from about $215 to $304.56.
- Cisco (CSCO), which yields 2.1%, ran from about $58 to $78.
- McDonald’s (MCD), which yields 2.37%, ran from about $293 to $313 so far.
- Procter & Gamble (PG), which yields 2.93%, fell from about $264 to $144.50.
That’s not bad at all.
Plus, once you factor in the yields for each, the Dogs outperformed the Dow Jones.
As for 2026, while the official list isn’t out just yet, here’s what’s likely to make the list.
- Verizon (VZ), which yields 6.84%
- Chevron (CVX), which yields 4.56%
- Merck (MRK), which yields 3.2%
- Procter & Gamble (PG), which yields 2.92%
- Amgen (AMGN), which yields 3.04%
- Coca-Cola (KO), which yields 2.92%
- Nike (NKE), which yields 2.72%
- UnitedHealth (UNH), which yields 2.68%
- Home Depot (HD), which yields 2.64%
- Johnson & Johnson (JNJ), which yields 2.51%
Historically, the Dogs of the Dow do very well.
The 2024 Dogs of the Dow did underperform the major indices in 2024. However, with dividends, investors still did well for the year.
The 2023 Dogs of the Dow returned an average of 10.1%, which came in below the 14.4% return on the Dow Jones’ Industrials. Still, with the appreciation in most of the 2023 Dogs coupled with dividends, investors still did well overall.
The 2022 Dogs of the Dow beat the major indices, even in a rough year.
In fact, while the Dogs of the Dow stocks fell 1.6% on the year, once you add in the dividend payouts, the Dogs returned 2% on the year. And while 2% may not sound like a big win, consider that, in 2022, one of the worst years on record since 2008, the NASDAQ lost 33%. The S&P 500 lost 19%. The Dow Jones lost about 9%.
In 2021, the Dogs of the Dow returned about 16.3%. While 2020 wasn’t a great year for the Dogs, most other years have done very well. In 2019, the Dogs were up 20%. In 2018, they were up about 1%, but still beat the Dow, which fell close to 6%. In 2017, the dogs were up 19%. In 2016, they were up 16%.
Read in Behind the Markets: Wall Street Stockpicker Names #1 Stock of 2026
The legendary quant who built one of Wall Street's most popular buying indicators just announced the #1 stock to buy for 2026.
And for a limited time, he's sharing this new recommendation live on-camera, completely free of charge.
He spent 50 years working alongside legendary investors like George Soros, Michael Steinhardt, Steve Cohen, and Paul Tudor Jones.
His work is coded into every Bloomberg terminal on Wall Street, and is still used by hundreds of banks, brokerages, and hedge funds to this day.
So why is he giving away his #1 buy recommendation for FREE?
It's all comes back to a shocking new market prediction for 2026.
This same legend - who accurately predicted the 2020 covid crash, the 2022 bear market, and the 2023 bank run - is now calling for an abrupt, surprising shift in the U.S. stock market.
The last time this happened, average investors lost over a fifth of their portfolio in just a matter of months.
So I got him to agree to an exclusive sit-down interview, where I got the whole story.
You'll get his #1 buy recommendation for 2026 when you click here.
To pick these recommendations, he consulted the same system that he used when CNBC's Jim Cramer said he'd never bet against him.
So I urge you to take advantage before it's too late.
Found this helpful? Share it with others.
Written by Ian Cooper
